Recordati Industria Chimica Market Performance
Recordati Industria Chimica (REC.MI) closed down 0.09 % during the trading session ending at 12:25 PM Central Europe on Friday 23 th. The share price at that time was approximately EUR 53.05.
- Shares outstanding: 208 million
- Market capitalization: EUR 11 billion
- Volume in last 24 hours: EUR 9.9 million of shares were traded
- 24‑hour change since the previous month end: up 0.28 %
The 200‑day simple moving average is EUR 50.28. The highest price in the past 52 weeks was EUR 54.45 on 11 December 2025, while the lowest was EUR 43.76 on 19 March 2026.
Recent Corporate Development
Recordati entered into a long‑term exclusive distribution agreement with BioGaia AB for the Spanish and Portuguese markets. The partnership aligns with BioGaia’s launch of a new probiotic product focused on colon health, which will initially roll out in the United Kingdom before expanding to other regions. Recordati’s role involves supplying the proprietary probiotic strain used in the product. The agreement is part of BioGaia’s broader strategy to diversify its product portfolio and strengthen its presence across European markets. No financial terms of the agreement were disclosed.
Related Stock Movements (Last 24 Hours)
| Stock | 24‑Hour Change | Current Price (EUR) | Market Capitalization (EUR bn) | P/E Ratio |
|---|---|---|---|---|
| A2a Spa (A2A.MI) | +0.62 % | 2.4 | 7.6 | 11.13 |
| Finecobank Spa (FBK.MI) | +2.49 % | 20.4 | 13.1 | 18.83 |
| Edison Spa (EDNR.MI) | +1.08 % | 1.86 | 8.8 | 56.19 |
| Italgas Spa (IG.MI) | +0.57 % | 8.76 | 9.8 | 12.73 |
| Telecom Italia Spa (TIT.MI) | +2.27 % | 5.65 | 12.3 | 43.12 |
Company Overview
Recordati Industria Chimica e Farmaceutica SpA, trading as Recordati SpA, is a multinational pharmaceutical company that researches, develops, manufactures, and markets both prescription and non‑prescription drugs, pharmaceutical chemicals, therapeutic products, and rare‑disease treatments. Its products are sold worldwide.
